Sectors
ABT
Abbott Laboratories
109.61
1 x 109.02
1 x 109.25
bid
ask
+
0.98
0.91%
09:39 AM
timesize
| Ytd | -12.52% | |
| 1y | -16.56% |
107.92
day range
109.82
82.56
52 week range
136.62
| Open | 109.82 | Prev Close | 108.62 | Low | 107.92 | High | 109.82 | Mkt Cap | 189.55B |
| Vol | 300.05K | Avg Vol | 12.51M | EPS | 5.21 | P/E | 21.02 | Forward P/E | 17.78 |
| Beta | 0.59 | Short Ratio | 1.83 | Inst. Own | 83.34% | Dividend | 2.52 | Div Yield | 2.33 |
| Ex Div Date | 07-15 | Earning | 07-16 | 50-d Avg | 95.71 | 200-d Avg | 107.68 | 1yr Est | 118.42 |
| Income Statement | |||
| Total Revenue | 12.59B | ||
| Revenues (USD) | 12.59B | ||
| Cost of Revenue | 5.33B | ||
| Gross Profit | 7.27B | ||
| Operating Expenses | 5.58B | ||
| Research and Development Expense | 892.00M | ||
| Selling, General and Administrative Expense | 4.03B | ||
| Operating Income | 1.69B | ||
| Interest Expense | 351.00M | ||
| Income Tax Expense | 596.00M | ||
| Net Income | 928.00M | ||
| Net Income Common Stock | 928.00M | ||
| Net Income Common Stock (USD) | 928.00M | ||
| Consolidated Income | 928.00M | ||
| Earnings per Basic Share | 0.53 | ||
| Earnings per Basic Share (USD) | 0.53 | ||
| Earnings per Diluted Share | 0.53 | ||
| Dividends per Basic Common Share | 0.63 | ||
| Earning Before Interest & Taxes (EBIT) | 1.88B | ||
| Earning Before Interest & Taxes (USD) | 1.88B | ||
| Weighted Average Shares | 1.74B | ||
| Weighted Average Shares Diluted | 1.74B | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.10B | ||
| Cash and Equivalents (USD) | 5.10B | ||
| Investments | 1.61B | ||
| Investments Current | 499.00M | ||
| Investments Non-Current | 1.11B | ||
| Trade and Non-Trade Receivables | 8.60B | ||
| Current Assets | 24.52B | ||
| Property, Plant & Equipment Net | 12.81B | ||
| Total Assets | 109.22B | ||
| Debt Current | 3.01B | ||
| Total Debt | 32.61B | ||
| Current Liabilities | 17.81B | ||
| Debt Non-Current | 29.60B | ||
| Total Liabilities | 57.45B | ||
| Accumulated Retained Earnings (Deficit) | 49.79B | ||
| Accumulated Other Comprehensive Income | -6.21B | ||
| Shareholders Equity | 51.76B | ||
| Shareholders Equity (USD) | 51.76B | ||
| Assets Non-Current | 84.70B | ||
| Total Debt (USD) | 32.61B | ||
| Goodwill and Intangible Assets | 52.46B | ||
| Inventory | 7.32B | ||
| Liabilities Non-Current | 39.64B | ||
| Trade and Non-Trade Payables | 4.79B | ||
| Tax Assets | 18.32B | ||
| Tax Liabilities | 411.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.06B | ||
| Net Cash Flow from Financing | -3.52B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.70B | ||
| Capital Expenditure | -497.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -164.00M | ||
| Issuance (Purchase) of Equity Shares | -1.04B | ||
| Issuance (Repayment) of Debt Securities | -1.37B | ||
| Payment of Dividends & Other Cash Distributions | -1.10B | ||
| Net Cash Flow from Investing | -673.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -26.00M | ||
| Net Cash Flow from Operations | 2.49B | ||
| Effect of Exchange Rate Changes on Cash | 4.00M | ||
| Share Based Compensation | 168.00M | ||